Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases

Summary

Using sensitive markers (such as thyroglobulin, etc) to evaluate the efficacy of strontium-89 chloride (Sr-89) in differentiated thyroid cancer with bone metastases with an aim to breaking out of its palliation effect for bone pain.

Timeline

Start

2022-07-13

Primary completion

2024-07-13

Completion

2025-07-13

Drugs

Indications